Neil D. Smith, MD Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 823 Commercial St, Rockport, ME 04856 Phone: 207-596-6599 |
Mira Regina Olson, M.D. Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 4 Glen Cove Dr Ste 10, Rockport, ME 04856 Phone: 207-301-5970 Fax: 207-301-5310 |
Eric Elton, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4 Glen Cove Dr Ste 10, Rockport, ME 04856 Phone: 207-301-5790 Fax: 207-301-5310 |
Jon Turner Stauffer, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4 Glen Cove Dr Ste 10, Rockport, ME 04856 Phone: 207-301-5970 |
Dr. Joseph J Minissale Jr., D.O. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4 Glen Cove Dr, Rockport, ME 04856 Phone: 207-301-5790 |
Steven A Rogers, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4 Glen Cove Dr Ste 10, Rockport, ME 04856 Phone: 207-661-2018 |
Kirk Patrick Bernadino, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6 Glen Cove Dr, Rockport, ME 04856 Phone: 207-921-8000 Fax: 207-921-5302 |
News Archive
RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 191 fully owned and operated outpatient imaging centers, today reported it has executed a definitive agreement to acquire Image Medical Corporation, the parent of eRAD, Inc., for $10.75 million in a combination of cash and promissory notes.
According to the United States Department of Agriculture, Americans are spending about half their food budget in restaurants. As it is widely known, food prepared away from home, as compared to food prepared at home, is often higher in calories, saturated fat, and sodium.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has notified the Company that it is extending the Prescription Drug User Fee Act goal date for the Company's supplemental biologics license application for XIAFLEX (collagenase clostridium histolyticum) for the treatment of Peyronie's disease from September 6, 2013 to December 6, 2013.
Almirall, S.A. and Ironwood Pharmaceuticals, Inc. today announced positive top-line results from a 26-week pivotal Phase 3 clinical trial assessing the efficacy and safety of once-daily dosing of linaclotide 266 mcg in patients with irritable bowel syndrome with constipation (IBS-C).
› Verified 3 days ago